Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
10/2003
10/22/2003CN1451013A Nucleophile-stable thoester generating compounds, method of production and use
10/22/2003CN1450064A 5-benzamido-1,3-dioxide cyclo group compound and preparation process thereof, and use in preparing protein kinase C inhibito medicine
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003CA2098020C Anti-viral compounds
10/16/2003WO2003085002A1 Cross-linked polymers based on cyclodextrins for removing polluting agents
10/16/2003US20030195354 For use as fungicide
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003CA2481832A1 Cross-linked polymers based on cyclodextrins for removing polluting agents
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003CN1124273C Fluoric diphenylacetylene compounds and preparing process and application thereof
10/15/2003CN1124261C Manufacture of polyene esters and acids
10/14/2003US6632955 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
10/14/2003US6632484 1,3-dioxane and/or cyclohexane derivatives; low positive or negative value of the dielectric anisotropy and can be used in liquid-crystal and electro-optical display elements
10/09/2003WO2003083063A2 Common ligand mimics: naphtoates
10/09/2003WO2003082850A1 Compounds for the controlled release of active aldehydes
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003US20030191326 Depolymerization of an aliphatic polyester by dissolving in liquid phase of the polyalkylene glycol ether, Heating, depressurization, cyclization to form glycolide, distillation; waste recycling
10/09/2003US20030191309 Administering N-substituted arylsulfonylamino hydroxamic acids to a patient for the treatment of arthritis and hepatic cirrhosis
10/09/2003US20030191166 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030190298 Use as skin lightening agents
10/08/2003CN1447803A Hyperpolarizable organic chromophores
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1447061A Method of removing organic pollutant from flyash
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630210 Pentafluorosulfuranylbenzene derivatives
10/02/2003WO2003080564A1 Menthol substituted antithrombotic pai-1 inhibitors
10/02/2003US20030187265 Process for synthesizing N-aryl piperazines with chiral N'-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
10/02/2003US20030187027 Dioxanes and uses thereof
10/01/2003EP1348907A1 Method of minimizing the concentration of toxic organic substances in fly-ash
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003EP0960095B1 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl- cyclohexan-1,3-diones with herbicidal effect
10/01/2003CN1446220A Method for the production of imidazo-[1,2-c] [2,3]-benzodiazepines and intermediates in production thereof
10/01/2003CN1446209A Process for preparation of cyclid esters and method for purification of the same
10/01/2003CN1446197A Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/01/2003CN1122666C New 2,3-dioxide indanol compounds, process for their preparation and pharmaceutical compositions containing them
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/25/2003WO2003078420A2 Process for making chiral 1,4-disubstituted piperazines
09/25/2003WO2003078417A1 Process for synthesizing chiral n-aryl piperazines
09/25/2003WO2003078409A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
09/25/2003US20030181552 Polymer additive compositions and articles comprising novel fluorinated and alkylated alditol derivatives
09/25/2003US20030181534 For use in antiperspirant gel sticks
09/25/2003US20030181514 Therapeutic compounds and methods
09/25/2003CA2479352A1 Carboxylic acid compound and a pharmaceutical agent comprising the compound as an active ingredient
09/25/2003CA2477906A1 Process for making chiral 1,4-disubstituted piperazines
09/24/2003EP1346990A1 Catalyst for synthesizing alkylene carbonates
09/24/2003EP1345891A1 Glucagon antagonist/inverse agonist
09/24/2003EP1345890A1 Glucagon antagonists/inverse agonists
09/24/2003CN1122029C Process for producing simvastatin
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/23/2003US6624189 Byrostatin analogues, synthetic methods and uses
09/23/2003US6624168 Bactericides, bacteriostats
09/23/2003CA2131366C Self-assembling diketopiperazine drug delivery system
09/23/2003CA2100123C The preparation of cyclic acetals of 3-formyl-2-butenyltriphenylphosphonium chloride
09/23/2003CA2094191C Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
09/18/2003WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
09/18/2003US20030176710 1,3-dioxane compounds containing oxo group
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176439 For therapy and prophylaxis of thromboembolic diseases and restenoses; reversible inhibitors of the blood clotting enzyme factor VIIa
09/18/2003CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/17/2003CN1443183A Process for preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivatives
09/17/2003CN1443179A Aniline derivatives
09/16/2003US6620468 Dioxane derivatives, and liquid-crystalline medium
09/16/2003CA2235421C Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2140252C A snow grooming device
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/11/2003US20030171462 Polyolefin compositions and articles comprising novel fluorinated and alkylated alditol derivatives
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/11/2003US20030170154 Plasma assisted catalytic treatment of gases
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341752A1 Novel indanylidene compounds
09/10/2003EP1341746A1 Liquid crystalline compounds
09/10/2003EP1341742A1 Method for producing compounds having a cf2o bridge
09/10/2003EP1159237B1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
09/10/2003EP0939627B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003EP0896533B1 Pentafluorobenzenesulfonamides and analogs
09/09/2003US6617350 Inhibitors of aspartyl protease
09/09/2003US6616990 Dopes for liquid crystals
09/04/2003WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166487 Normally liquid, omega-hydrofluoroalkyl ether compounds (and selected mixtures thereof) have a saturated perfluoroaliphatic chain of carbon atoms interrupted by one or more ether oxygen atoms. The compounds can be prepared, by decarboxylation of
09/03/2003EP1340752A1 Process for the production of semi synthetic statins via novel intermediates
09/03/2003EP1339673A1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use
09/03/2003CN1440461A Process for preparation of dihydroxy esters and derivatives thereof
09/03/2003CN1120164C 5-benzyloxy-trimethylene carbonate and its prepn.
09/02/2003US6613803 Treating, preventing or ameliorating pain
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
08/2003
08/28/2003WO2003070719A1 Bryostatin analogues, synthetic methods and uses
08/28/2003WO2003070714A1 Fluorous acetylation
08/28/2003WO2003070713A1 Substituted aryl alkenoic acid heterocyclic amides possessing pungent taste
08/28/2003WO2003070676A1 Process for producing optically active 3-halo-1,2-propanediol derivative
08/28/2003US20030162840 Novel process for preparing salmeterol
08/28/2003US20030162817 Pentafluorobenzenesulfonamides and analogs
08/28/2003US20030162778 Carbocyclic side chain containing metalloprotease inhibitors
08/28/2003US20030162098 A lithium electrochemical cell with an electrolyte having cyclic carbonate rint size equal to or larger than a six member ring, helps to make anode passivation film ionically conductive, thus, eliminate voltage delay
08/28/2003US20030161860 Novel substituted aryl alkenoic acid heterocyclic amides
08/27/2003EP1339121A2 Organic cyclic carbonate additives for nonaqueous electrolyte in alkali metal electrochemical cells
08/26/2003US6610892 Process for preparing 2,7-dimethyl-2,4,6-octatrienal monoacetals
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 103